Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,431,111
in 18 filings, $21.0M under 10b5-1 plans

Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2012-02-10 FORMELA JEAN FRANCOIS Director Grant or award · Option to Purchase Common Stock +3,500 3,500
2011-05-20 Wheeler Patrick M Chief Financial Officer Grant or award · Options to Purchase Common Stock −20,000 20,000
2011-05-20 BRISTOW MICHAEL R President and CEO Grant or award · Option to Purchase Common Stock −30,000 30,000
2011-05-20 Ozeroff Christopher David SVP and General Counsel Grant or award · Option to Purchase Common Stock −20,000 20,000
2010-07-07 Ozeroff Christopher David SVP & GENERAL COUNSEL Other disposition −2,051 41,758
2010-07-02 Ozeroff Christopher David SVP & GENERAL COUNSEL Exercise or conversion +4,101 $0.06 $246 43,809
2010-07-02 Ozeroff Christopher David SVP & GENERAL COUNSEL Exercise or conversion · Option to purchase Common Stock +4,101 0
2010-05-26 Ozeroff Christopher David SVP & GENERAL COUNSEL Other disposition −39,709 39,708
2010-03-29 Atlas Venture Fund VII L P 10% owner Sale −140,000 $7.56 $1.1M 1,337,612
2010-03-29 FORMELA JEAN FRANCOIS Director Sale −140,000 $7.56 $1.1M 1,337,612
2010-03-29 Grais Linda S Director Sale −23,600 $7.98 $188K 679,098
2010-03-29 Grais Linda S Director Sale −187,209 $7.30 $1.4M 491,889
2010-02-18 BRISTOW MICHAEL R President and CEO Grant or award · Option to Purchase Common Stock +16,000 16,000
2010-02-18 Wheeler Patrick M acting Chief Financial Officer Grant or award · Option to Purchase Common Stock +6,400 6,400
2010-02-18 Ozeroff Christopher David SVP & GENERAL COUNSEL Grant or award · Option to Purchase Common Stock +6,400 6,400
2010-02-05 SOBEL BURTON E Director Grant or award · Option to Purchase Common Stock +3,500 3,500
2010-02-05 FORMELA JEAN FRANCOIS Director Grant or award · Option to Purchase Common Stock +3,500 3,500
2010-02-05 ZABRISKIE JOHN L Director Grant or award · Option to Purchase Common Stock +3,500 3,500
2010-02-05 Grais Linda S Director Grant or award · Option to Purchase Common Stock +3,500 3,500
2010-02-05 PENDERGAST MARY K Director Grant or award · Option to Purchase Common Stock +3,500 3,500

Page 28 of 41 · 802 trades